# Psyomics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/psyomics

- Industry: Healthcare Specialists
- Headquarters: Cambridge, UK
- Website: www.psyomics.com/
- Total disclosed funding: $3.2M
- Latest round: Series B (Jun 27, 2019)
- Investors on record: 3

## About

Founded in 2015 by Sabine Bahn (CMO) and others and based in Cambridge, UK, Psyomics Ltd. operates as a developer of proteomic diagnostics treatment for mental health patients. In March 2024, Psyomics Ltd. raised GBP 3.7 million in venture funding from Parkwalk Advisors. The March 2024 financing values Psyomics Ltd. at GBP 12.21 million post-money. As of 2024, the company is led by its CEO, Melinda Rees.

The company provides its primary product, Censeo, which is a web-based medical device designed for mental health triage and assessment. Censeo enhances clinical decision-making accuracy and increases efficiency by streamlining the mental health assessment process.

The organization plans to use the March 2024 funding to enhance its AI-enabled medical device, Censeo.

## Funding rounds

- Series B, Jun 27, 2019, $2.6M — Parkwalk Advisors
- Series A, Jul 4, 2016, $0.6M — Cambridge Enterprise, Parkwalk Advisors, Martlet Capital

## Investors

- Cambridge Enterprise — Series A
- Parkwalk Advisors (https://capitalatlas.ai/funds/parkwalk-advisors) — Series A, Series B
- Martlet Capital (https://capitalatlas.ai/funds/martlet-capital) — Series A